{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 DHEA-SO4 Calibration Verification Material",
        "IMMULITE\u00ae 2000 Third Generation TSH Calibration Verification Material",
        "IMMULITE\u00ae 2000 Intact PTH Calibration Verification Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K140258",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133128"
    ],
    "Regulatory Class": "Class I Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 31, 2014",
    "Summary Letter Received Date": "February 3, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "DHEA-SO4",
        "TSH",
        "Intact PTH"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA plasma",
        "Dialysis samples"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE\u00ae 2000 Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Calibration verification",
        "Lyophilized preparation"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibration Verification Material",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE\u00ae 2000 DHEA-SO4, Third Generation TSH, and Intact PTH Calibration Verification Materials as quality control for calibration verification of IMMULITE\u00ae 2000 assays",
    "Indications for Use Summary": "For in vitro diagnostic verification of calibration of IMMULITE DHEA-SO4, Third Generation TSH, and Intact PTH assays on IMMULITE 2000 systems",
    "fda_folder": "Clinical Chemistry"
}